Quanterix Corporation (QTRX)
7.60
-0.21 (-2.69%)
At close: Feb 20, 2025, 3:59 PM
7.58
-0.26%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 7.51 |
| Market Cap | 292.78M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -7.31 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 7.66 |
| Volume | 314,932 |
| Avg. Volume (20D) | 636,884 |
| Open | 7.78 |
| Previous Close | 7.81 |
| Day's Range | 7.54 - 7.85 |
| 52-Week Range | 7.49 - 29.70 |
| Beta | undefined |
About QTRX
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in variou...
Industry Medical - Devices
Sector Healthcare
IPO Date Dec 7, 2017
Employees 441
Stock Exchange NASDAQ
Ticker Symbol QTRX
Website https://www.quanterix.com
Analyst Forecast
According to 4 analyst ratings, the average rating for QTRX stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 228.95% from the latest price.
Buy 75.00%
Hold 25.00%
Sell 0.00%
Next Earnings Release
Quanterix Corporation is scheduled to release its earnings on Mar 17, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-18.26%
Quanterix shares are trading lower. The company re...
Unlock content with
Pro Subscription
